Congestive heart failure risk in cancer patients treated with vascular endothelial growth factor tyrosine kinase inhibitors: a systematic review and meta-analysis of 36 clinical trials

British journal of clinical pharmacology

Volumn 78, Issue 4, 2014, Pages 748-762

  Qi, Wei Xiang ^a   Shen, Zan ^a   Tang, Li Na ^a   Yao, Yang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

congestive heart failure; meta analysis; VEGFR TKIs

Indexed keywords

PROTEIN KINASE INHIBITOR; VASCULOTROPIN RECEPTOR;

ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; CLINICAL TRIAL (TOPIC); HEART FAILURE; HUMAN; META ANALYSIS; NEOPLASM; ODDS RATIO; PUBLISHING; RISK;

CLINICAL TRIALS AS TOPIC; HEART FAILURE; HUMANS; NEOPLASMS; ODDS RATIO; PROTEIN KINASE INHIBITORS; PUBLICATION BIAS; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RISK;

EID: 84964316190     PISSN: None     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12387     Document Type: Article

References (0)